{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T06:56:00Z","timestamp":1778828160802,"version":"3.51.4"},"reference-count":15,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.3201\/eid1905.121852","type":"journal-article","created":{"date-parts":[[2013,4,16]],"date-time":"2013-04-16T15:04:41Z","timestamp":1366124681000},"page":"802-805","source":"Crossref","is-referenced-by-count":23,"title":["Genetic Analysis of Primaquine Tolerance in a Patient with Relapsing Vivax Malaria"],"prefix":"10.3201","volume":"19","author":[{"given":"A. Taylor","family":"Bright","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thamer","family":"Alenazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Shokoples","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel","family":"Tarning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giacomo M.","family":"Paganotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas J.","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanley","family":"Houston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth A.","family":"Winzeler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie K.","family":"Yanow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid1905.121852-201304161508-R1","doi-asserted-by":"publisher","first-page":"e774","DOI":"10.1371\/journal.pntd.0000774","article-title":"The international limits and population at risk of Plasmodium vivax transmission in 2009.","volume":"4","author":"Guerra","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"key-10.3201\/eid1905.121852-201304161508-R2","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1097\/QCO.0b013e32832f14c1","article-title":"New developments in Plasmodium vivax malaria: severe disease and the rise of chloroquine resistance.","volume":"22","author":"Price","year":"2009","journal-title":"Curr Opin Infect Dis"},{"key":"key-10.3201\/eid1905.121852-201304161508-R3","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1128\/CMR.00008-09","article-title":"Resistance to therapies for infection by Plasmodium vivax.","volume":"22","author":"Baird","year":"2009","journal-title":"Clin Microbiol Rev"},{"key":"key-10.3201\/eid1905.121852-201304161508-R4","doi-asserted-by":"publisher","first-page":"E232","DOI":"10.1111\/j.1469-0691.2012.03820.x","article-title":"Relapse of imported vivax malaria despite standard-dose primaquine therapy: an investigation with molecular genotyping analyses.","volume":"18","author":"Chiang","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"key-10.3201\/eid1905.121852-201304161508-R5","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/1475-2875-11-214","article-title":"Relapse of imported Plasmodium vivax malaria is related to primaquine dose: a retrospective study.","volume":"11","author":"Townell","year":"2012","journal-title":"Malar J"},{"key":"key-10.3201\/eid1905.121852-201304161508-R6","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1086\/338566","article-title":"Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria.","volume":"185","author":"Kublin","year":"2002","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid1905.121852-201304161508-R7","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1046\/j.1365-2958.2003.03627.x","article-title":"Multiple transporters associated with malaria parasite responses to chloroquine and quinine.","volume":"49","author":"Mu","year":"2003","journal-title":"Mol Microbiol"},{"key":"key-10.3201\/eid1905.121852-201304161508-R8","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1038\/35002615","article-title":"Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum.","volume":"403","author":"Reed","year":"2000","journal-title":"Nature"},{"key":"key-10.3201\/eid1905.121852-201304161508-R9","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1038\/ng.2373","article-title":"The malaria parasite Plasmodium vivax exhibits greater genetic diversity than Plasmodium falciparum.","volume":"44","author":"Neafsey","year":"2012","journal-title":"Nat Genet"},{"key":"key-10.3201\/eid1905.121852-201304161508-R10","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.2174\/138945006779025347","article-title":"Pharmacogenetics of cytochromes P450 in tropical medicine.","volume":"7","author":"Ribeiro","year":"2006","journal-title":"Curr Drug Targets"},{"key":"key-10.3201\/eid1905.121852-201304161508-R11","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/1475-2875-11-259","article-title":"CYP450 phenotyping and accurate mass identification of metabolites of the 8-aminoquinoline, anti-malarial drug primaquine.","volume":"11","author":"Pybus","year":"2012","journal-title":"Malar J"},{"key":"key-10.3201\/eid1905.121852-201304161508-R12","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1093\/infdis\/jir629","article-title":"Human genetic variation is associated with Plasmodium falciparum drug resistance.","volume":"204","author":"Paganotti","year":"2011","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid1905.121852-201304161508-R13","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1517\/14622416.3.2.229","article-title":"CYP2D6 allele frequency in European Caucasians, Asians, Africans and their descendants.","volume":"3","author":"Bradford","year":"2002","journal-title":"Pharmacogenomics"},{"key":"key-10.3201\/eid1905.121852-201304161508-R14","doi-asserted-by":"crossref","first-page":"402","DOI":"10.4269\/ajtmh.2006.75.402","article-title":"Primaquine: report from CDC expert meeting on malaria chemoprophylaxis I.","volume":"75","author":"Hill","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"key-10.3201\/eid1905.121852-201304161508-R15","doi-asserted-by":"publisher","first-page":"7687","DOI":"10.1074\/jbc.M806944200","article-title":"Disruption of a Plasmodium falciparum multidrug resistance-associated protein (PfMRP) alters its fitness and transport of antimalarial drugs and glutathione.","volume":"284","author":"Raj","year":"2009","journal-title":"J Biol Chem"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/19\/5\/12-1852_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T04:20:14Z","timestamp":1733286014000},"score":1,"resource":{"primary":{"URL":"http:\/\/wwwnc.cdc.gov\/eid\/article\/19\/5\/12-1852_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"URL":"https:\/\/doi.org\/10.3201\/eid1905.121852","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}